Search research articles
Contact Us
Filters
Showing results (221-230 of 233) with videos related to
Page
of 24
Sort By:
The Journal of Clinical Psychiatry
|
July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapy
J Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry
|
August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
P J McGrath, J W Stewart, E Petkova, et al.
The Journal of Clinical Psychiatry
|
May 4, 2007
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study
David Michelson, Lenard A Adler, Jay D Amsterdam, et al.
Journal of Affective Disorders
|
February 16, 2008
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy
Sunil S Bhar, Lois A Gelfand, Sabine P Schmid, et al.
Immunological Investigations
|
January 1, 1997
Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipients
M J Evans, Y Edwards-Spring, J Myers, et al.
Neuroimmunomodulation
|
February 6, 2004
Neuroendocrine aspects of chronic fatigue syndrome
Dimitris A Papanicolaou, Jay D Amsterdam, Susan Levine, et al.
Archives of General Psychiatry
|
April 6, 2005
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression
Steven D Hollon, Robert J DeRubeis, Richard C Shelton, et al.
Neuroimmunomodulation
|
October 7, 2004
Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health
Timothy R Gerrity, Dimitris A Papanicolaou, Jay D Amsterdam, et al.
Archives of General Psychiatry
|
April 6, 2005
Cognitive therapy vs medications in the treatment of moderate to severe depression
Robert J DeRubeis, Steven D Hollon, Jay D Amsterdam, et al.
The Journal of Clinical Psychiatry
|
November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study
Mauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 233) with videos related to
Sort By:
Page
of 24
The Journal of Clinical Psychiatry
|
July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapy
J Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry
|
August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
P J McGrath, J W Stewart, E Petkova, et al.
The Journal of Clinical Psychiatry
|
May 4, 2007
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study
David Michelson, Lenard A Adler, Jay D Amsterdam, et al.
Journal of Affective Disorders
|
February 16, 2008
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy
Sunil S Bhar, Lois A Gelfand, Sabine P Schmid, et al.
Immunological Investigations
|
January 1, 1997
Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipients
M J Evans, Y Edwards-Spring, J Myers, et al.
Neuroimmunomodulation
|
February 6, 2004
Neuroendocrine aspects of chronic fatigue syndrome
Dimitris A Papanicolaou, Jay D Amsterdam, Susan Levine, et al.
Archives of General Psychiatry
|
April 6, 2005
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression
Steven D Hollon, Robert J DeRubeis, Richard C Shelton, et al.
Neuroimmunomodulation
|
October 7, 2004
Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health
Timothy R Gerrity, Dimitris A Papanicolaou, Jay D Amsterdam, et al.
Archives of General Psychiatry
|
April 6, 2005
Cognitive therapy vs medications in the treatment of moderate to severe depression
Robert J DeRubeis, Steven D Hollon, Jay D Amsterdam, et al.
The Journal of Clinical Psychiatry
|
November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study
Mauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
Page
of 24